Page last updated: 2024-12-07

cryptating agent 221

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cryptating agent 221: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123438
SCHEMBL ID25928
MeSH IDM0151665

Synonyms (32)

Synonym
4,7,13,16,21-pentaoxa-1,10-diazabicyclo[8.8.5]tricosane
4,7,13,16,21-pentaoxa-1,10-diazabicyclo[8.8.5.]tricosane
nsc321059
31364-42-8
nsc-321059
kryptofix 221
4,7,13,16,21-pentaoxa-1,10-diazabicyclo[8.8.5]tricosane, 98%
FT-0660588
AKOS015916737
einecs 250-592-1
nsc 321059
4,7,13,16,21-pentaoxa-1,10-diazabicyclo(8.8.5)tricosane
cryptand-221
cryptating agent 221
cryptand 221
SCHEMBL25928
kryptofix(r) 221
4,7,13,16,21-pentaoxa-1,10-diazabicyclo[8.8.5]tricosane #
kryptofix-221
HDLXPNDSLDLJHF-UHFFFAOYSA-N
4,7,16,21-pentaoxa-1,10-diazabicyclo[8.8.5.]tricosane
mfcd00005108
J-200342
DTXSID60185286
AS-70036
kryptofix(r)221
BCP14291
A875929
4,7,13,16,21-pentaoxa-1,10-diazabicyclo-[8.8.5]tricosane
kryptofix221
(4,7,13,16,21-pentaoxa-1,10-diazabicyclo[8.8.5]tricosane)
AC-37052
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (25.00)18.7374
1990's4 (50.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.25 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]